One of the biggest winners in my High-Yield Investing premium newsletter portfolio is also one of the easiest investments we’ve ever made.
All we had to do was buy it, and wait. That’s it.
That’s because it was built for a single purpose: to throw off a rising stream of tax-advantaged rental income.
It’s done that and more. Not only are we earning a 7% yield on our original purchase price, but we’re sitting on some fantastic capital gains to boot.
It just goes to prove what I’ve been saying for the past few weeks (and for my entire career, really). Successful dividend investing does not have to be complicated — and the high yields are out there if you know where to look.
Today, I want to introduce you to the company and explain why it’s been such a great performer for us over the years. It certainly isn’t alone, either. And if history is any guide, stocks like this should continue to produce compounding returns for us for many years to come.
Best Dividend Stocks To Buy For 2023: MAWSON INFRASTRUCTURE GROUP INC(MIGI)
Mawson Infrastructure Group Inc., a digital infrastructure provider, operates in cryptocurrency mining and digital asset infrastructure activities in the United States and Australia. It owns and operates modular data centers. The company matches energy infrastructure with mobile data center solutions enabling the proliferation of blockchain technology. The company is based in North Sydney, Australia.
Advisors’ Opinion:
- [By ]
GoodRx (NASDAQ:GDRX) and Mawson Infrastructure Group (NASDAQ:MIGI) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, profitability, earnings, analyst recommendations, institutional ownership, dividends and valuation.
Best Dividend Stocks To Buy For 2023: Neovasc Inc.(NVCN)
Neovasc is a specialty medical device company that develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products include the Tiara technology in development for the transcatheter treatment of mitral valve disease, the Neovasc Reducer for the treatment of refractory angina.
In 2009, Neovasc started initial activities to develop novel technologies for catheter-based treatment of mitral valve disease. Based on the early positive results of these activities, the Company formally launched a program to develop the Tiara. Neovasc established a separate entity, Neovasc Tiara Inc. (NTI), in March 2013 to develop and own the intellectual property related to the Tiara (Neovasc has transferred all intellectual property related to Tiara to NTI). On February 3, 2014, Neovasc announced the first human implant of the Tiara under special access compassionate use exemptions. Advisors’ Opinion:
- [By Max Byerly]
Neovasc Inc (NASDAQ:NVCN) (TSE:NVC) shares dropped 10% during trading on Monday . The company traded as low as $2.38 and last traded at $2.65. Approximately 3,137 shares traded hands during mid-day trading, a decline of 99% from the average daily volume of 507,141 shares. The stock had previously closed at $2.41.
- [By Logan Wallace]
Cerus (NASDAQ:CERS) and Neovasc (NASDAQ:NVCN) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, profitability, valuation, risk and earnings.
Best Dividend Stocks To Buy For 2023: XP Inc.(XP)
XP Inc. provides financial products and services in Brazil. It offers securities brokerage, private pension plans, commercial, and investment banking products, such as loan operations and transactions in the foreign exchange markets and deposits; product structuring and capital markets services for corporate clients and issuers of fixed income products; advisory services for mass-affluent and institutional clients; and wealth management services for high-net-worth customers and institutional clients. The company also offers XP Educação, an online financial education portal that offers seminars, classes, and learning tools to help teach individuals on topics, such as basics of investing, techniques, and investment strategies, as well as insurance brokerage services. In addition, it operates XP Platform, an open product platform that provides clients to access investment products in the market, including equity and fixed income securities, mutual and hedge funds, structured products, life insurance, pension plans, real-estate investment funds, and others. The company was founded in 2001 and is based in São Paulo, Brazil.
Advisors’ Opinion:
- [By Stephan Byrd]
Experience Points (CURRENCY:XP) traded 15.2% lower against the U.S. dollar during the 1-day period ending at 22:00 PM E.T. on May 22nd. Experience Points has a market cap of $52.73 million and approximately $733,204.00 worth of Experience Points was traded on exchanges in the last day. One Experience Points coin can currently be bought for about $0.0002 or 0.00000003 BTC on major cryptocurrency exchanges including CryptoBridge, CoinExchange, Crex24 and Coinhouse. Over the last seven days, Experience Points has traded up 54.5% against the U.S. dollar.
